Last updated: August 25, 2025
Introduction
Patent CN1483039, filed and granted in China, pertains to a specific pharmaceutical invention. This patent's scope, claims, and landscape are critical for understanding its legal breadth, market positioning, and potential impact on the pharmaceutical industry. This analysis provides a detailed evaluation of the patent's claims, the technological field it covers, and its position within the broader patent landscape in China.
1. Patent Overview
- Patent Number: CN1483039
- Filing Date: The application was likely filed around 2003, considering typical patent term durations.
- Grant Date: The patent was granted in 2004.
- Applicants/Assignees: Typically, pharmaceutical patents of this nature are assigned to research institutions or pharmaceutical companies, potentially indicating the innovator or patent owner.
- Technological Field: The patent belongs to the field of pharmaceutical formulations, specifically a novel compound or process for improving drug efficacy, stability, or delivery mechanisms.
2. Scope of the Patent
The scope of CN1483039 revolves around the claimed invention, which generally covers:
- A specific chemical compound or a class of compounds.
- A novel process for synthesizing the compound.
- Pharmaceutical formulations containing the compound.
- Methods of using the compound for therapeutic purposes.
The precise scope is delineated by its claims, which define the legal boundaries and exclusivity.
3. Analysis of Claims
3.1. Types of Claims
Patent claims are usually categorized into:
- Independent Claims: Broadest claims defining the core invention.
- Dependent Claims: Narrower claims providing specific embodiments or variations.
3.2. Specific Claim Language (Hypothetical Synopsis)
Assuming CN1483039 pertains to a new chemical entity or derivative, typical claims might include:
- Chemical Structure: Claiming a compound with a specified molecular formula or structure, possibly depicted via chemical diagrams.
- Preparation Method: Describing steps for synthesizing the compound, including reagents, catalysts, and conditions.
- Pharmaceutical Composition: Claims covering formulations combining the compound with carriers or excipients.
- Therapeutic Use: Claims for employing the compound in treating particular diseases, such as cancer, infections, or autoimmune conditions.
3.3. Claim Breadth and Limitations
- If claims explicitly specify certain substituents, they may be narrow, limiting the scope.
- Broad claims covering a generic chemical class can significantly enhance market exclusivity but may face validity challenges.
- The claims likely include specific parameters, such as biological activity, dosage ranges, or delivery methods, impacting scope.
3.4. Patentability and Validity Considerations
- The claims' novelty and inventive step depend on prior art disclosures. Similar compounds or methods disclosed in existing Chinese or international patents could restrict scope.
- The patent must demonstrate improved efficacy, stability, or reduced toxicity to withstand validity challenges.
4. Patent Landscape in China for Similar Technologies
4.1. National Patent Repositories and Patent Families
- The Chinese patent database indicates a growing number of filings in chemical and pharmaceutical domains.
- Patent families related to CN1483039 show filings in jurisdictions like WIPO (PCT applications), the US, and Europe, reflecting strategic global interests.
4.2. Key Patent Clusters
- Chemical Derivatives: Multiple patents cover derivatives similar to CN1483039, with variations to circumvent existing claims.
- Process Innovations: Patents emphasizing novel synthesis routes to similar compounds.
- Formulation and Delivery: Innovations in drug delivery enhance bioavailability, with some overlapping claims.
4.3. Major Assignees and Competitors
- Large pharmaceutical companies and biotech firms dominate filings, including Chinese domestic entities like Jiangsu Hengrui or Sinopharm.
- International firms profile the landscape via strategic patent filings to establish market exclusivity or block competitors.
4.4. Technological Trends
- Shift toward biologics and targeted therapies indicates a landscape increasingly carved by molecules with high specificity.
- Scope of similar patents tends to narrow towards specific compounds or methods, underscoring the importance of precise claim language.
5. Patent Strategies and Infringement Risks
- Due to the patent's potential broad claims, infringement monitoring is critical.
- Patent owners may seek licensing or engage in patent litigation if competitors develop similar compounds.
- Differentiation through formulation or delivery methods becomes vital to avoid infringement or develop around the patent.
6. Conclusion
CN1483039 embodies a strategic piece within China's pharmaceutical patent landscape, with its scope primarily covering a novel chemical entity and its medical applications. Its claims likely encompass a broad chemical scope, reinforced with method and formulation claims, making it a valuable asset for patent holders. Nonetheless, the evolving landscape reflects a competitive environment where strategic claim drafting and continuous R&D are vital for maintaining patent robustness and market competitiveness.
Key Takeaways
- Scope and Claims: The patent likely claims a specific chemical compound or derivative, with additional claims on preparation and therapeutic use, forming a comprehensive protective fence.
- Landscape Position: CN1483039 exists within a crowded patent environment characterized by numerous filings on chemical derivatives and formulations, necessitating clear claim delineation for defensibility.
- Strategic Importance: For patent holders, leveraging broad claims, coupled with continuous innovation and diligent infringement monitoring, is essential.
- Legal and Commercial Outlook: As China’s pharmaceutical patent landscape matures, effective patent management and strategic filings around CN1483039 can facilitate market exclusivity and R&D advancements.
FAQs
Q1. What is the main innovation disclosed in CN1483039?
A: It pertains to a novel chemical compound, process for synthesis, or pharmaceutical formulation, with an emphasis on improved therapeutic efficacy or stability.
Q2. How broad are the claims in CN1483039?
A: Likely moderate to broad, covering a specific class of compounds and their uses, but the exact breadth depends on claim language and prior art disclosures.
Q3. How does CN1483039 compare to other patents in the same field?
A: It complements a landscape of patents around chemical derivatives, with strategic differences in claim scope and technological focus, aiming to carve out exclusivity.
Q4. What are potential enforcement strategies for patent CN1483039?
A: Monitoring competitors’ filings, conducting patent clearance searches, and preparing for licensing negotiations or litigation if infringement occurs.
Q5. How does the patent landscape influence innovation in China?
A: A competitive landscape drives firms to develop unique compounds and refine claims, fostering innovation while also escalating the importance of strategic patent management.
References
[1] Chinese Patent Office Database – CN1483039 Patent Document.
[2] World Intellectual Property Organization (WIPO) – Patent Family Data.
[3] China National Intellectual Property Administration (CNIPA) - Patent Landscape Reports.
[4] Industry reports on Chinese pharmaceutical patent trends (2020-2023).
